Atlas Trials

A Study of Furmonertinib Combined With Radiotherapy for Non-small Cell Lung Cancer With Oligoprogression

Clinical trial NCT04970693 · UNKNOWN

Trial details

NCT number
NCT04970693
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung CancerOligoprogressive
Start date
2021-06-01
Primary completion
2024-01-31
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.